Hamilton Capital Partners Inc.’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.2M Buy
43,560
+1,625
+4% +$1.66M 1.52% 21
2026
Q1
$38.6M Buy
41,935
+2,336
+6% +$2.37M 1.3% 22
2025
Q4
$42.6M Sell
39,599
-2,833
-7% -$2.71M 1.56% 18
2025
Q3
$32.4M Buy
42,432
+10,638
+33% +$7.92M 1.34% 22
2025
Q2
$24.8M Buy
31,794
+4,726
+17% +$3.67M 1.26% 29
2025
Q1
$22.4M Buy
27,068
+4,451
+20% +$3.7M 1.44% 24
2024
Q4
$17.5M Buy
22,617
+1,979
+10% +$1.64M 1.3% 26
2024
Q3
$18.3M Sell
20,638
-920
-4% -$827K 1.58% 20
2024
Q2
$19.5M Buy
21,558
+1,453
+7% +$1.16M 2.09% 13
2024
Q1
$15.6M Buy
20,105
+8,326
+71% +$5.93M 1.89% 14
2023
Q4
$6.87M Buy
+11,779
New +$6.88M 1.37% 31

Other funds holding LLY

Hamilton Capital Partners Inc.'s LLY Position: Q2 2026 in Review

Hamilton Capital Partners Inc. increased its Eli Lilly (LLY) stake by 3.9% in Q2 2026, buying an estimated $1.66M and bringing the position to 43,560 shares worth $52.2M. The position accounts for 1.52% of the portfolio, ranked #21.

Hamilton Capital Partners Inc. first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hamilton Capital Partners Inc. held 43,560 shares of Eli Lilly worth $52.2M as of Q2 2026.
  • Hamilton Capital Partners Inc. bought 1,625 Eli Lilly shares in Q2 2026, an estimated $1.66M.
  • Eli Lilly made up 1.52% of Hamilton Capital Partners Inc.'s portfolio in Q2 2026, its #21 holding.
  • Hamilton Capital Partners Inc. first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hamilton Capital Partners Inc.'s 13F filing for Q2 2026, filed 14 Aug 2026.